Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00586
|
|||||
| Drug Name |
Nitrendipine
|
|||||
| Synonyms |
1A Pharma, Nitren; AL, Nitrendipin; AbZ, Nitre; Acis, Nitren; Atid, Nitrendipin; Basics, Nitrendipin; Bay-e-5009; Baylotensin; Bayotensin; Baypress; Baypress (TN); Bayvit, Nitrendipino; Beta, Nitrendipin; Biochemie, Nitrendi; Bylotensin; Ct, nitrendipin von; Deiten; Gericin; Heumann, Nitrendipin; Jutapress; KSK, Nitrend; Lich, Nitren; Lindo, Nitrendipin; N-144; Nidrel; Niprina; Nitre AbZ; Nitre Puren; Nitre-Puren; NitrePuren; Nitregamma; Nitren 1A Pharma; Nitren Lich;Nitren acis; Nitrend KSK; Nitrendepat; Nitrendi Biochemie; Nitrendidoc; Nitrendimerck; Nitrendipin; Nitrendipin AL; Nitrendipin Apogepha; Nitrendipin Atid; Nitrendipin Basics; Nitrendipin Heumann; Nitrendipin Lindo; Nitrendipin Stada; Nitrendipin beta; Nitrendipin corax; Nitrendipin von ct; Nitrendipin-corax; Nitrendipincorax; Nitrendipino; Nitrendipino Bayvit; Nitrendipinum; Nitrensal; Nitrepin; Nitrepress; Pharma, Nitren 1A; Stada, Nitrendipin; Tensogradal; Trendinol; Vastensium; Von ct, nitrendipin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H20N2O6
|
|||||
| Canonical SMILES |
CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C
|
|||||
| InChI |
InChI=1S/C18H20N2O6/c1-5-26-18(22)15-11(3)19-10(2)14(17(21)25-4)16(15)12-7-6-8-13(9-12)20(23)24/h6-9,16,19H,5H2,1-4H3
|
|||||
| InChIKey |
PVHUJELLJLJGLN-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 39562-70-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 360.4 | Topological Polar Surface Area | 110 | ||
| Heavy Atom Count | 26 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
2.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10588972
, 11120001
, 11120489
, 11120977
, 11121464
, 11121944
, 11147084
, 11342013
, 11362196
, 11362533
, 11364838
, 11365095
, 11367400
, 11367657
, 11369962
, 11370337
, 11370338
, 11371895
, 11373258
, 11374614
, 11375819
, 11378130
, 11466944
, 11468064
, 11485206
, 11486717
, 11487598
, 11489381
, 11490783
, 11492902
, 11495715
, 12013715
, 14925926
, 17405440
, 24277857
, 26612495
, 26680401
, 26719687
, 26747121
, 26751794
, 26751795
, 29223601
, 46386549
, 46508817
, 5055566
, 6014122
, 7847695
, 8152776
, 855994
, 9915
|
|||||
| ChEBI ID |
CHEBI:7582
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Analogue-based Drug Discovery | |||||
| 2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.